Observe Medical Asa Net Assets
Observe Medical Asa net assets. Based on the latest financial reports, Observe Medical Asa (OBSRV) has net assets worth Nkr29.96 Million NOK (≈ $3.15 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr101.17 Million ≈ $10.65 Million USD) and total liabilities (Nkr71.21 Million ≈ $7.49 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore OBSRV year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr29.96 Million |
| % of Total Assets | 29.61% |
| Annual Growth Rate | 8.24% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 66.9 |
Net Assets of Observe Medical Asa (2016–2025)
Net assets of Observe Medical Asa from 2016 to 2025. This chart illustrates how Observe Medical Asa's net assets have evolved over time, based on quarterly financial data. See Observe Medical Asa (OBSRV) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Observe Medical Asa (2016–2025)
The table below shows the annual net assets of Observe Medical Asa from 2016 to 2025. For live market cap and overall valuation, see Observe Medical Asa (OBSRV) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr29.96 Million ≈ $3.15 Million |
+24.28% |
| 2024-12-31 | Nkr24.11 Million ≈ $2.54 Million |
-78.49% |
| 2023-12-31 | Nkr112.08 Million ≈ $11.79 Million |
-18.96% |
| 2022-12-31 | Nkr138.31 Million ≈ $14.55 Million |
+1079.30% |
| 2021-12-31 | Nkr-14.12 Million ≈ $-1.49 Million |
-169.41% |
| 2020-12-31 | Nkr20.35 Million ≈ $2.14 Million |
+39.93% |
| 2019-12-31 | Nkr14.54 Million ≈ $1.53 Million |
-13.56% |
| 2018-12-31 | Nkr16.82 Million ≈ $1.77 Million |
+47.65% |
| 2017-12-31 | Nkr11.39 Million ≈ $1.20 Million |
-22.47% |
| 2016-12-31 | Nkr14.70 Million ≈ $1.55 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Observe Medical Asa's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 33432000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Observe Medical Asa Net Assets Breakdown (December 2025)
Observe Medical Asa net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Nkr57.18 Million | 190.87% |
| Other Components | Nkr307.10 Million | 1025.05% |
| Total Equity | Nkr29.96 Million | 100.00% |
Observe Medical Asa Competitors by Market Cap
The table below lists competitors of Observe Medical Asa ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Prochem S.A.
WAR:PRM
|
$12.58 Million |
|
Embelton Ltd
AU:EMB
|
$12.60 Million |
|
Forgame Holdings Limited
F:FH0
|
$12.60 Million |
|
Volex Plc
LSE:VLX
|
$12.60 Million |
|
Mercan Kimya Sanayi ve Ticaret AS
IS:MERCN
|
$12.58 Million |
|
Devonian Health Group Inc
V:GSD
|
$12.57 Million |
|
Personas Social Inc
V:PRSN
|
$12.56 Million |
|
Lanthanein Resources Ltd
AU:LNR
|
$12.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Observe Medical Asa's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 24,107,000 to 29,959,000, a change of 5,852,000 (24.3%).
- Net loss of 48,639,000 reduced equity.
- Share repurchases of 50,445,000 reduced equity.
- New share issuances of 50,445,000 increased equity.
- Other factors increased equity by 54,491,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-48.64 Million | -162.35% |
| Share Repurchases | Nkr50.45 Million | -168.38% |
| Share Issuances | Nkr50.45 Million | +168.38% |
| Other Changes | Nkr54.49 Million | +181.89% |
| Total Change | Nkr- | 24.28% |
Book Value vs Market Value Analysis
This analysis compares Observe Medical Asa's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.98x to 3.99x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | Nkr0.90 | Nkr0.88 | x |
| 2017-12-31 | Nkr0.70 | Nkr0.88 | x |
| 2018-12-31 | Nkr1.01 | Nkr0.88 | x |
| 2019-12-31 | Nkr0.87 | Nkr0.88 | x |
| 2020-12-31 | Nkr1.04 | Nkr0.88 | x |
| 2021-12-31 | Nkr-0.58 | Nkr0.88 | x |
| 2022-12-31 | Nkr2.59 | Nkr0.88 | x |
| 2023-12-31 | Nkr8.82 | Nkr0.88 | x |
| 2024-12-31 | Nkr1.25 | Nkr0.88 | x |
| 2025-12-31 | Nkr0.22 | Nkr0.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Observe Medical Asa utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -162.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -258.57%
- • Asset Turnover: 0.19x
- • Equity Multiplier: 3.38x
- Recent ROE (-162.35%) is below the historical average (-129.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -71.93% | -1720.81% | 0.01x | 4.70x | Nkr-12.04 Million |
| 2017 | -152.45% | -8782.87% | 0.00x | 5.62x | Nkr-18.51 Million |
| 2018 | 13.52% | 2141.22% | 0.00x | 3.50x | Nkr591.37K |
| 2019 | -116.34% | -9576.73% | 0.00x | 3.81x | Nkr-18.37 Million |
| 2020 | -181.19% | -1245.12% | 0.03x | 4.31x | Nkr-38.90 Million |
| 2021 | 0.00% | -109.48% | 0.34x | 0.00x | Nkr-24.91 Million |
| 2022 | -36.73% | -260.24% | 0.09x | 1.56x | Nkr-64.63 Million |
| 2023 | -57.00% | -228.65% | 0.11x | 2.18x | Nkr-75.10 Million |
| 2024 | -526.68% | -686.93% | 0.12x | 6.16x | Nkr-129.38 Million |
| 2025 | -162.35% | -258.57% | 0.19x | 3.38x | Nkr-51.63 Million |
Industry Comparison
This section compares Observe Medical Asa's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $85,815,699
- Average return on equity (ROE) among peers: -140.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Observe Medical Asa (OBSRV) | Nkr29.96 Million | -71.93% | 2.38x | $12.58 Million |
| Gentian Diagnostics AS (GENT) | $194.05 Million | 23.34% | 0.18x | $64.10 Million |
| Lifecare AS (LIFE) | $1.69 Million | -444.70% | 0.35x | $17.98 Million |
| Medistim ASA (MEDI) | $61.71 Million | 0.00% | 0.20x | $578.78 Million |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more